Met Life Investment Management, LLC Icad Inc Transaction History

Met Life Investment Management, LLC

$17.1 Billion
Q3 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$10.11 - $17.56 $90,160 - $156,600	-8,918 Closed	0 $0
Q2 2021 Jun 21, 2023	BUY	$14.9 - $20.82 $132,878 - $185,672	8,918 New	8,918 $154,000
Q1 2021 May 17, 2024	BUY	$12.57 - $21.22 $112,099 - $189,239	8,918 New	8,918 $189,000
Q1 2021 Jun 26, 2023	BUY	$12.57 - $21.22 $112,099 - $189,239	8,918 New	8,918 $189 Million
Q1 2021 Mar 22, 2023	SELL	$12.57 - $21.22 $9,729 - $16,424	-774 Reduced 7.99%	8,918 $189,000
Q1 2021 May 14, 2021	SELL	$12.57 - $21.22 $9,729 - $16,424	-774 Reduced 7.99%	8,918 $189,000
Q4 2020 May 24, 2024	SELL	$8.73 - $14.56 $4,862 - $8,109	-557 Reduced 5.43%	9,692 $127,000
Q4 2020 Jun 22, 2023	BUY	$8.73 - $14.56 $84,611 - $141,115	9,692 New	9,692 $127,000
Q4 2020 Mar 22, 2023	SELL	$8.73 - $14.56 $4,862 - $8,109	-557 Reduced 5.43%	9,692 $127,000
Q4 2020 Feb 16, 2021	SELL	$8.73 - $14.56 $4,862 - $8,109	-557 Reduced 5.43%	9,692 $128,000
Q3 2020 May 24, 2024	SELL	$8.56 - $11.6 $1,147 - $1,554	-134 Reduced 1.29%	10,249 $90.3 Million
Q3 2020 Jun 26, 2023	BUY	$8.56 - $11.6 $87,731 - $118,888	10,249 New	10,249 $90,000
Q3 2020 Mar 22, 2023	SELL	$8.56 - $11.6 $1,147 - $1,554	-134 Reduced 1.29%	10,249 $90,000
Q3 2020 Nov 13, 2020	SELL	$8.56 - $11.6 $1,147 - $1,554	-134 Reduced 1.29%	10,249 $90,000
Q2 2020 May 24, 2024	BUY	$6.63 - $12.85 $68,839 - $133,421	10,383 New	10,383 $104 Million
Q2 2020 Jun 26, 2023	BUY	$6.63 - $12.85 $68,839 - $133,421	10,383 New	10,383 $103,000
Q2 2020 Mar 22, 2023	BUY	$6.63 - $12.85 $68,839 - $133,421	10,383 New	10,383 $103,000
Q2 2020 Aug 14, 2020	BUY	$6.63 - $12.85 $68,839 - $133,421	10,383 New	10,383 $104,000

Others Institutions Holding ICAD

# of Institutions

Shares Held

5.45M

Call Options Held

3.6K

Put Options Held

14.6K

View Full List

About ICAD INC

Ticker ICAD
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 25,333,900
Market Cap $42.6M
Description
iCAD, Inc. provides image analysis, workflow solutions, and radiation therapy for the treatment of cancer in the United States. It operates through two segments, Cancer Detection and Cancer Therapy. The company offers PowerLook platform, which hosts the AI algorithm solutions and manages the communications between imaging acquisition systems, an...

More about ICAD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Met Life Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Met Life Investment Management, LLC with notifications on news.

Account